SELLAS Life Sciences Gr Analyst Ratings
SELLAS Life Sciences Gr Analyst Ratings
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a reiterated with a price target of $0.00 to $3.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $0.98, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 206.18% | Cantor Fitzgerald | → $3 | Reiterates | Overweight → Overweight |
| 09/07/2023 | 206.18% | Cantor Fitzgerald | → $3 | Reiterates | Overweight → Overweight |
| 11/15/2022 | 716.49% | Alliance Global Partners | $14 → $8 | Maintains | Buy |
| 06/28/2022 | 512.37% | Cantor Fitzgerald | $10 → $6 | Maintains | Overweight |
| 07/21/2021 | 1737.11% | Cantor Fitzgerald | → $18 | Initiates Coverage On | → Overweight |
| 11/15/2019 | 1124.74% | Maxim Group | → $12 | Upgrades | Hold → Buy |
| 04/08/2019 | 359.28% | Alliance Global Partners | → $4.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/22/2023 | 206.18% | 坎托·菲茨杰拉德 | → 3 美元 | 重申 | 超重 → 超重 |
| 09/07/2023 | 206.18% | 坎托·菲茨杰拉德 | → 3 美元 | 重申 | 超重 → 超重 |
| 11/15/2022 | 716.49% | 联盟全球合作伙伴 | 14 美元 → 8 美元 | 维护 | 买 |
| 06/28/2022 | 512.37% | 坎托·菲茨杰拉德 | 10 美元 → 6 美元 | 维护 | 超重 |
| 07/21/2021 | 1737.11% | 坎托·菲茨杰拉德 | → 18 美元 | 启动覆盖范围开启 | → 超重 |
| 11/15/2019 | 1124.74% | Maxim 集团 | → 12 美元 | 升级 | 持有 → 买入 |
| 2019 年 8 月 4 日 | 359.28% | 联盟全球合作伙伴 | → 4.5 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for SELLAS Life Sciences Gr (SLS)?
SELLAS生命科学集团（SLS）的目标价格是多少？
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on November 22, 2023. The analyst firm set a price target for $3.00 expecting SLS to rise to within 12 months (a possible 206.18% upside). 2 analyst firms have reported ratings in the last year.
坎托·菲茨杰拉德于2023年11月22日公布了SELLAS Life Sciences Gr（纳斯达克股票代码：SLS）的最新目标股价。该分析公司将目标股价定为3.00美元，预计SLS将在12个月内升至12个月内（可能上涨206.18％）。去年有2家分析公司公布了评级。
What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?
SELLAS Life Sciences Gr（SLS）的最新分析师评级是多少？
The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Cantor Fitzgerald, and SELLAS Life Sciences Gr reiterated their overweight rating.
SELLAS Life Sciences Gr（纳斯达克股票代码：SLS）的最新分析师评级由坎托·菲茨杰拉德提供，SELLAS Life Sciences Gr重申了其增持评级。
When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?
SELLAS Life Sciences Gr（SLS）的下一份分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与SELLAS Life Sciences Gr的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。SELLAS Life Sciences Gr的最新评级是在2023年11月22日公布的，因此您应该预计下一个评级将在2024年11月22日左右公布。
Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?
分析师评级 SELLAS Life Sciences Gr (SLS) 是否正确？
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a reiterated with a price target of $0.00 to $3.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $0.98, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的SELLAS生命科学集团（SLS）评级，目标股价为0.00美元至3.00美元。SELLAS Life Sciences Gr（SLS）的当前交易价格为0.98美元，在分析师的预测区间内。
